Research on the role of MYL3 in the diagnosis and treatment of hypertrophic cardiomyopathy has predominantly concentrated on genetic variants, with limited information available regarding the function of MYL3 itself in the regulation of cardiac hypertrophy. Here, MYL3 is linked to cardiac hypertrophy.